Lawrence Van Helleputte

571 total citations
12 papers, 433 citations indexed

About

Lawrence Van Helleputte is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lawrence Van Helleputte has authored 12 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lawrence Van Helleputte's work include Histone Deacetylase Inhibitors Research (5 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Hereditary Neurological Disorders (3 papers). Lawrence Van Helleputte is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Amyotrophic Lateral Sclerosis Research (3 papers) and Hereditary Neurological Disorders (3 papers). Lawrence Van Helleputte collaborates with scholars based in Belgium, United States and United Kingdom. Lawrence Van Helleputte's co-authors include Ludo Van Den Bosch, Veronick Benoy, Robert Prior, Philip Van Damme, Tom Jaspers, Matthew Jarpe, Elisabeth Rossaert, Pieter Vanden Berghe, Wanda Haeck and Eveliina Pollari and has published in prestigious journals such as Brain, Scientific Reports and Brain Research.

In The Last Decade

Lawrence Van Helleputte

12 papers receiving 430 citations

Peers

Lawrence Van Helleputte

CMN

NEURO

ONCOL

PHYSI

Filomena D’Amato Italy

Eleni Zamba‐Papanicolaou Cyprus

Farah Chamaa Lebanon

Ina Woods Ireland

Laura Rué Belgium

Kon-Ping Lin Taiwan

Lindsey D. Goodman United States

Nadiya Byts Finland

Ilaria Cervellini United Kingdom

Filomena D’Amato Italy

Lawrence Van Helleputte

169 ×0.7

125 ×0.9

CMN

68 ×0.7

NEURO

43 ×0.6

ONCOL

91 ×1.3

PHYSI

Citations per year, relative to Lawrence Van Helleputte Lawrence Van Helleputte (= 1×) peers Filomena D’Amato

Countries citing papers authored by Lawrence Van Helleputte

Since Specialization

Citations

This map shows the geographic impact of Lawrence Van Helleputte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Van Helleputte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Van Helleputte more than expected).

Fields of papers citing papers by Lawrence Van Helleputte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Van Helleputte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Van Helleputte. The network helps show where Lawrence Van Helleputte may publish in the future.

Co-authorship network of co-authors of Lawrence Van Helleputte

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Van Helleputte. A scholar is included among the top collaborators of Lawrence Van Helleputte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Van Helleputte. Lawrence Van Helleputte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Casazza, Andrea, Lawrence Van Helleputte, Péter Pokreisz, et al.. (2022). PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index. Molecular Cancer Therapeutics. 21(4). 568–581. 5 indexed citations

Goossens, Chloë, Sarah Derde, Lawrence Van Helleputte, et al.. (2021). Impact of prolonged sepsis on neural and muscular components of muscle contractions in a mouse model. Journal of Cachexia Sarcopenia and Muscle. 12(2). 443–455. 10 indexed citations

Rossaert, Elisabeth, Eveliina Pollari, Tom Jaspers, et al.. (2019). Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model. Acta Neuropathologica Communications. 7(1). 107–107. 66 indexed citations

Jardí, Ferran, Michaël R. Laurent, Nari Kim, et al.. (2018). Testosterone boosts physical activity in male mice via dopaminergic pathways. Scientific Reports. 8(1). 957–957. 45 indexed citations

Prior, Robert, et al.. (2018). HDAC6 as a potential therapeutic target for peripheral nerve disorders. Expert Opinion on Therapeutic Targets. 22(12). 993–1007. 29 indexed citations

Helleputte, Lawrence Van, Dana P. Cook, Elisabeth Rossaert, et al.. (2017). Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth. Neurobiology of Disease. 111. 59–69. 54 indexed citations

Prior, Robert, Lawrence Van Helleputte, Veronick Benoy, & Ludo Van Den Bosch. (2017). Defective axonal transport: A common pathological mechanism in inherited and acquired peripheral neuropathies. Neurobiology of Disease. 105. 300–320. 81 indexed citations

Benoy, Veronick, Lawrence Van Helleputte, Robert Prior, et al.. (2017). HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease. Brain. 141(3). 673–687. 98 indexed citations

Staats, Kim A., Susann Schönefeldt, Lawrence Van Helleputte, et al.. (2015). Transcriptional upregulation of myelin components in spontaneous myelin basic protein-deficient mice. Brain Research. 1606. 125–132. 3 indexed citations

10.

Staats, Kim A., Susann Schönefeldt, Lawrence Van Helleputte, et al.. (2015). C-kit is important for SOD1G93A mouse survival independent of mast cells. Neuroscience. 301. 415–420. 5 indexed citations

11.

Helleputte, Lawrence Van, Veronick Benoy, & Ludo Van Den Bosch. (2014). The role of histone deacetylase 6 (HDAC6) in neurodegeneration. Lirias (KU Leuven). 1–1. 23 indexed citations

12.

Staats, Kim A., Lawrence Van Helleputte, Ashley Jones, et al.. (2013). Genetic ablation of phospholipase C delta 1 increases survival in SOD1G93A mice. Neurobiology of Disease. 60. 11–17. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact